The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer
出版年份 2016 全文链接
标题
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer
作者
关键词
-
出版物
ONCOGENE
Volume 36, Issue 1, Pages 122-132
出版商
Springer Nature
发表日期
2016-06-13
DOI
10.1038/onc.2016.184
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The hypoxic tumor microenvironment: A driving force for breast cancer progression
- (2016) Gregg L. Semenza BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells
- (2016) Michelle Gonzales-Cope et al. BMC GENOMICS
- BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells
- (2016) Saeed Alghamdi et al. Stem Cell Research & Therapy
- Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement
- (2015) Surojeet Sengupta et al. BREAST CANCER RESEARCH AND TREATMENT
- Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy
- (2015) Elias E. Stratikopoulos et al. CANCER CELL
- Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality
- (2015) A. McIntyre et al. EMBO Molecular Medicine
- The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation
- (2015) Qiong Wu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase
- (2015) Thomas R. Cox et al. NATURE
- Nanog Requires BRD4 to Maintain Murine Embryonic Stem Cell Pluripotency and Is Suppressed by Bromodomain Inhibitor JQ1 Together with Lefty1
- (2015) Gillian A. Horne et al. STEM CELLS AND DEVELOPMENT
- JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer
- (2015) Haifeng Qiu et al. Oncotarget
- The BET Family Member BRD4 Interacts with OCT4 and Regulates Pluripotency Gene Expression
- (2015) Tao Wu et al. Stem Cell Reports
- A systematic review of bevacizumab efficacy in breast cancer
- (2014) Iben Kümler et al. CANCER TREATMENT REVIEWS
- Hallmarks of triple negative breast cancer emerging at last?
- (2014) Rosa Bernardi et al. CELL RESEARCH
- Pre-Clinical Analysis of Changes in Intra-cellular Biochemistry of Glioblastoma Multiforme (GBM) Cells Due to c-Myc Silencing
- (2014) Vishal Rajagopalan et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma
- (2014) Dhong Hyun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
- (2014) Yujie Tang et al. NATURE MEDICINE
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- Bromodomain Protein BRD4 Is Required for Estrogen Receptor-Dependent Enhancer Activation and Gene Transcription
- (2014) Sankari Nagarajan et al. Cell Reports
- The machinery of macroautophagy
- (2013) Yuchen Feng et al. CELL RESEARCH
- BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
- (2013) P. Bandopadhayay et al. CLINICAL CANCER RESEARCH
- Epigenetic regulation of hypoxia-responsive gene expression: Focusing on chromatin and DNA modifications
- (2013) Ya-Ping Tsai et al. INTERNATIONAL JOURNAL OF CANCER
- BRG1 and BRM Chromatin-Remodeling Complexes Regulate the Hypoxia Response by Acting as Coactivators for a Subset of Hypoxia-Inducible Transcription Factor Target Genes
- (2013) J. A. Sena et al. MOLECULAR AND CELLULAR BIOLOGY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Lysyl Oxidase Plays a Critical Role in Endothelial Cell Stimulation to Drive Tumor Angiogenesis
- (2012) A.-M. Baker et al. CANCER RESEARCH
- New strategies for targeting the hypoxic tumour microenvironment in breast cancer
- (2012) Carol Ward et al. CANCER TREATMENT REVIEWS
- Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy
- (2012) A. McIntyre et al. CLINICAL CANCER RESEARCH
- Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cellsin vitro
- (2012) Roben G. Gieling et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Targeting Epigenetic Readers in Cancer
- (2012) Mark A. Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins
- (2012) W. W. Lockwood et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
- (2011) J. Schodel et al. BLOOD
- Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
- (2011) Y. Lou et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia
- (2011) Tomasz Rzymski et al. CELL CYCLE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation
- (2011) Ludwig Dubois et al. RADIOTHERAPY AND ONCOLOGY
- Erratum: Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
- (2010) F M Buffa et al. BRITISH JOURNAL OF CANCER
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- ViaComplex: software for landscape analysis of gene expression networks in genomic context
- (2009) Mauro A. A. Castro et al. BIOINFORMATICS
- The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
- (2009) E Y Tan et al. BRITISH JOURNAL OF CANCER
- MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
- (2009) C. V. Dang et al. CLINICAL CANCER RESEARCH
- The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell Growths
- (2009) Pawel Swietach et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
- (2009) Axel Grothey et al. Nature Reviews Clinical Oncology
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- SWI/SNF: A chromatin-remodelling complex with a role in carcinogenesis
- (2008) Gary M. Halliday et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now